ERBB2 and breast cancer: Breast cancer (BC) is the most common malignancy in women [1] and biomarkers including estrogen receptor (ER)s, progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are routinely performed for therapeutic decision-making [2].